Trial Search Results

Diagnostic and Prognostic Biomarkers for High-impact Chronic Pain: Development and Validation

To identify diagnostic and prognostic biomarker signatures of recovery versus having persisting high-impact chronic pain and functional disability in adults with Chronic Musculoskeletal Pain.

Stanford is currently accepting patients for this trial.

Lead Sponsor:

Stanford University

Collaborator: National Institute of Neurological Disorders and Stroke (NINDS)

Stanford Investigator(s):


Inclusion Criteria:

   - 1) Inclusion criteria: Adults (18-80 years; ~64% female expected based on clinic
   distribution) with chronic MSP as categorized by the World Health Organization (WHO).

Exclusion Criteria:

   - 1) Chronic musculoskeletal pain (MSP) explained by inflammatory disease (e.g.,
   rheumatoid arthritis, lupus) or CP with a primary diagnosis other than chronic MSP
   (e.g., neuropathic pain), (2) significant cognitive impairment, (3) MRI
   contraindication, (4) medical or psychiatric problems interfering with the study, (5)
   current medicolegal factors (e.g., open disability claim), (6) plans for surgery
   during the study, (7) pregnancy and (8) Children under the age of 18 will not be
   included in the study.

Ages Eligible for Study

18 Years - 80 Years

Genders Eligible for Study


Now accepting new patients

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Anne Cunniffe Marcy, MSBH